Phase
Condition
Lung Injury
Respiratory Failure
Treatment
manual titration
FreeO2
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
COPD or suspected COPD ( Age>40, active or smoking history > 10pack/years), -
Acute exacerbation (increasing dyspnea recently)
One or more of the following criteria: increased sputum, modification of sputumpurulence,increased dyspnea,
Moderate oxygen therapy: Oxygen flow < 8 lpm (or FiO2 < 0.60) to maintain a SpO2 >or = 92% (for long term oxygen therapy, the oxygen flow must be greater than baselineflow to maintain SpO2 > or = 92%)
Exclusion
Exclusion Criteria:
Patient refusal
COPD exacerbation with diagnosis highly related to pulmonary embolism, cardiacpulmonary edema, pneumothorax or sedative overdose
No SpO2 signal
Encephalopathy score > 2
Delirium
Other respiratory support needed (intubation or NIV)
Patient on withdrawal life support
Advance neoplasia (palliative stage) or terminal respiratory distress
Unavailability of FreeO2 device at the randomisation
Non optimal patient collaboration
Study Design
Study Description
Connect with a study center
Institut Universitaire de Cardiologie et de Pneumologie de Québec
Quebec, G1V4G5
CanadaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.